Swedish Study on STroke After TAVR

Swedish Study on STroke After TAVR. A Nationwide All-comers Study of the Risk of Stroke After Transcatheter Aortic Valve Replacemant

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04086836

Acronym

SWESTAT

Enrollment

4600

Registered

2019-09-12

Start date

2019-07-01

Completion date

2020-02-01

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Disease, Stroke

Keywords

TAVR, Stroke

Brief summary

This study aims at studying the frequency of late stroke after transcatheter aortic valve replacement/implantation

Detailed description

Since the start of transcatheter aortic valve implnatations/replacements (TAVR/TAVI) implantations in Sweden in 2008 all procedures have been added to a national database, which now contains 5000+ procedures. At the same time, all admissions to the hospital is also recorded with diagnosis in a separate database. We intend to make a nation-wide complete follow up of all TAVR/TAVI patients in swede that has received the diagnosis of stroke after the implantation. In addition data will also be collected from the national stroke database for detailed information of the cases

Interventions

DEVICETAVR

Patient recieving a TAVR

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

All patients that has under TAVR/TAVI in Sweden between 2008 and 2018

Exclusion criteria

Patients unable to follow up due to emigration or missing social security number

Design outcomes

Primary

Measure	Time frame	Description
Stroke	5 year	Stroke as defined by the national stroke database

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026